Percio Gulko, MD, joins Mount Sinai from North Shore-LIJ in Manhasset, New York where he served as Professor and Director of the Laboratory of Experimental Rheumatology at the Center for Genomics and Human Genetics at the Feinstein Institute for Medical Research. He was also a Professor of Molecular Medicine at Hofstra University and an Attending Physician in the Division of Rheumatology at North Shore University Hospital.

Dr. Gulko completed his medical degree, internship and clinical fellowship in Rheumatology at the Universidade Federal do Rio Grande do Sul. Porto Alegre in Brazil. He came to the United States as a research fellow in the Division of Rheumatology at the University of Alabama at Birmingham, and later completed his residency in Internal Medicine at the Medical College of Georgia in Augusta. He also completed a rheumatology fellowship at the National Institutes of Health, and was a faculty member at the Divisions of Autoimmune and Molecular Disease and Rheumatology at Columbia University’s College of Physicians and Surgeons before joining the Feinstein Institute.

Dr. Gulko has received numerous grants from the NIH, given lectures both nationally and internationally and has been published in leading peer-reviewed journals throughout the world. He serves on the editorial board of Genes and Immunity and Physiological Genomics and is a member of the American College of Rheumatology.

Teresina Laragione, PhD, is an Associate Professor at the Icahn School of Medicine at Mount Sinai. Originally from Italy, she obtained a degree in Pharmaceutical Chemistry and Technology at the University of Pisa and attended the prestigious Mario Negri Institute for Pharmacological Research in Milan. Teresina joined the Gulko team in 2004 and since then she has focused her research on identifying the role of synovial fibroblast in Rheumatoid Arthritis. She is the leading author and contributes to several lab publications. http://www.ncbi.nlm.nih.gov/pubmed/?term=Laragione+t

 Carolyn Harris is a Senior Associate Researcher at Gulko Lab. She obtained her Bachelor of Science degree in Molecular Biology at Long Island University. She spent 17 years at the Institute for Basic Research, located in Staten Island, working in the Developmental Cell Biology lab. Next, she worked at Rutgers University, serving as the Lab Manager in the NeuroPharmacoGenetics Lab in the Center for Alcohol Studies. She then moved to the Icahn School of Medicine at Mount Sinai, working in a Clinical Immunology lab. Carolyn will work on discovering the role fibroblast-like synoviocytes play in RA development.

Daniel M Toth, PhD, received his doctoral degree in Pharmaceutical Science at University of Pecs, Hungary. He worked for pharmaceutical company Gedeon Richter Plc. where the purpose of his projects was to develop new types of analgesic drugs especially affecting on the peripheral nervous system. From 2014 Daniel did his postdoctoral work at Rush University Medical Center in Chicago. He addressed scientific questions with a particular focus on epigenetic alterations in autoimmune arthritis. Currently, he is a scientist in Gulko Laboratory at Mount Sinai and continues to explore genetic aspects of arthritis especially on synovial fibroblasts.